147 related articles for article (PubMed ID: 33799544)
1. Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis.
Weerasuriya CK; Harris RC; Quaife M; McQuaid CF; White RG; Gomez GB
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33799544
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of routine adolescent vaccination with an M72/AS01
Harris RC; Quaife M; Weerasuriya C; Gomez GB; Sumner T; Bozzani F; White RG
Nat Commun; 2022 Feb; 13(1):602. PubMed ID: 35105879
[TBL] [Abstract][Full Text] [Related]
3. New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
BMC Med; 2023 Aug; 21(1):288. PubMed ID: 37542319
[TBL] [Abstract][Full Text] [Related]
4. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.
Weerasuriya CK; Harris RC; McQuaid CF; Bozzani F; Ruan Y; Li R; Li T; Rade K; Rao R; Ginsberg AM; Gomez GB; White RG
BMC Med; 2021 Feb; 19(1):60. PubMed ID: 33632218
[TBL] [Abstract][Full Text] [Related]
5. The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.
Clark RA; Portnoy A; Weerasuriya CK; Sumner T; Bakker R; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
medRxiv; 2023 Sep; ():. PubMed ID: 37808744
[TBL] [Abstract][Full Text] [Related]
6. Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.
Harris RC; Sumner T; Knight GM; Evans T; Cardenas V; Chen C; White RG
Lancet Glob Health; 2019 Feb; 7(2):e209-e218. PubMed ID: 30630775
[TBL] [Abstract][Full Text] [Related]
7. New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01
Clark RA; Weerasuriya CK; Portnoy A; Mukandavire C; Quaife M; Bakker R; Scarponi D; Harris RC; Rade K; Mattoo SK; Tumu D; Menzies NA; White RG
medRxiv; 2023 Jul; ():. PubMed ID: 36865172
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.
Jayawardana S; Weerasuriya CK; Pelzer PT; Seeley J; Harris RC; Tameris M; Tait D; White RG; Asaria M
NPJ Vaccines; 2022 Nov; 7(1):138. PubMed ID: 36344523
[TBL] [Abstract][Full Text] [Related]
9. Mathematical models of cervical cancer prevention in the Asia Pacific region.
Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves.
Kim SY; Salomon JA; Goldie SJ
Bull World Health Organ; 2007 Nov; 85(11):833-42. PubMed ID: 18038073
[TBL] [Abstract][Full Text] [Related]
11. Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness.
Arinaminpathy N; Nandi A; Vijayan S; Jha N; Nair SA; Kumta S; Dewan P; Rade K; Vadera B; Rao R; Sachdeva KS
BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34610905
[TBL] [Abstract][Full Text] [Related]
12. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
[TBL] [Abstract][Full Text] [Related]
13. Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
Xia R; Sun S; Shen M; Zhang L; Zhuang G
Vaccine; 2019 Sep; 37(39):5868-5876. PubMed ID: 31443991
[TBL] [Abstract][Full Text] [Related]
14. Assessing the impacts of COVID-19 vaccination programme's timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries.
Liu Y; Procter SR; Pearson CAB; Montero AM; Torres-Rueda S; Asfaw E; Uzochukwu B; Drake T; Bergren E; Eggo RM; Ruiz F; Ndembi N; Nonvignon J; Jit M; Vassall A
BMC Med; 2023 Mar; 21(1):85. PubMed ID: 36882868
[TBL] [Abstract][Full Text] [Related]
15. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
16. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
[TBL] [Abstract][Full Text] [Related]
17. The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
Bartsch SM; Stokes-Cawley OJ; Buekens P; Asti L; Bottazzi ME; Strych U; Wedlock PT; Mitgang EA; Meymandi S; Falcon-Lezama JA; Hotez PJ; Lee BY
Vaccine; 2020 Apr; 38(16):3261-3270. PubMed ID: 32171575
[TBL] [Abstract][Full Text] [Related]
18. Modelling the health and economic impacts ofM72/AS01
Sumner T; Clark RA; Mukandavire C; Portnoy A; Weerasuriya CK; Bakker R; Scarponi D; Hatherill M; Menzies NA; White RG
Vaccine; 2024 Feb; 42(6):1311-1318. PubMed ID: 38307747
[TBL] [Abstract][Full Text] [Related]
19. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India.
Shrestha S; Chatterjee S; Rao KD; Dowdy DW
J R Soc Interface; 2016 Mar; 13(116):. PubMed ID: 27009179
[TBL] [Abstract][Full Text] [Related]
20. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
